In our study, only one patient with a long history of heavily pretreated MDS presented a rapid evolution to acute leukemia (3 months after start of eltrombopag), making it difficult to evaluate a possible cause–effect relationship between TPO-RA treatment and leukemic progression. This evidence concerns the gene TPO and acute leukemia.